RxDoctor Payments Data

Taylor Reif, MD

Adult Reconstructive Orthopaedic Surgery · New York, NYNPI 1568704476

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $20,800 of the $31,615 with a category attached, or 65.8%. It is spread thinly across 18 manufacturers, the largest accounting for just 20.5%. Reporting peaked in 2023 at $9,477 and has fallen 51.7% since, to $4,580 in 2025.

$31,615in general payments, 2019–2025

Across 78 payments — averaging $405.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthopediatrics Corp.$6K
  • Paragon 28, Inc.$6K
  • Bodycad USA Corp$5K
  • Nuvasive Specialized Orthopedics, Inc.$4K
  • Wishbone Medical Inc.$4K
  • Globus Medical$1K
  • plus $5K from 12 others

What the payments were for

  • Consulting fees$20,80066%
  • Travel & lodging$5,55718%
  • Food & beverage$5,25817%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,615 in reported general payments places this provider in the 65th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.

See all adult reconstructive orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$72,234
Medicare patients
86
Services billed
212

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult reconstructive orthopaedic surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →